Research Topics
Genomes and GenesSpecies | Christopher KenneySummaryAffiliation: Baylor College of Medicine Country: USA Publications
| Collaborators |
Detail Information
Publications
Tetrabenazine in the treatment of hyperkinetic movement disordersChristopher Kenney
Department of Neurology, Parkinson s Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX, USA
Expert Rev Neurother 6:7-17. 2006....- Distinguishing psychogenic and essential tremorChristopher Kenney
Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, United States
J Neurol Sci 263:94-9. 2007..In conclusion, a history of tremor with sudden onset and spontaneous remissions along with distractibility and suggestibility on examination are good predictors of PT and help differentiate it from ET... - Rotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndromeChristopher Kenney
Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, Texas 77030, USA
Expert Opin Pharmacother 8:1329-35. 2007..Advantages over existing dopamine agonists include once-daily administration, absence of food interactions, maintenance of stable plasma levels and utility in patients with swallowing difficulties... - Botulinum toxin in the treatment of blepharospasm and hemifacial spasmC Kenney
Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
J Neural Transm 115:585-91. 2008..This article summarizes the existing medical literature which indicates that botulinum toxin is the treatment of choice for blepharospasm and hemifacial spasm... - Short-term and long-term safety of deep brain stimulation in the treatment of movement disordersChristopher Kenney
Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
J Neurosurg 106:621-5. 2007..The object of this study was to assess the long-term safety of deep brain stimulation (DBS) in a large population of patients with a variety of movement disorders... - Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disordersChristopher Kenney
Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
Mov Disord 22:193-7. 2007..6%), and akathisia (7.6%). Comparison of log-likelihood ratios revealed that age was a reliable predictor of Parkinsonism (P < 0.0001). TBZ is a safe and effective drug for the long-term treatment of hyperkinetic movement disorders... - Autopsy-proven Huntington's disease with 29 trinucleotide repeatsChristopher Kenney
Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
Mov Disord 22:127-30. 2007..A minimum of 36 CAG repeats is usually reported in patients with clinical features of HD; 30 to 35 repeats represent an intermediate range. Here we report a 65-year-old male with autopsy-proven HD and 29 CAG repeats... - Short-term effects of tetrabenazine on chorea associated with Huntington's diseaseChristopher Kenney
Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
Mov Disord 22:10-3. 2007..2 hours to a maximum of 8.1 hours (mean = 5.4 +/- 1.3). No patient experienced an adverse event related to TBZ or its withdrawal. During short-term follow-up after a single dose, TBZ improves chorea for approximately 5 hours... - Is history of depression a contraindication to treatment with tetrabenazine?Christopher Kenney
Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
Clin Neuropharmacol 29:259-64. 2006..To determine whether a history of depression predisposes hyperkinetic patients treated with tetrabenazine (TBZ) to a recurrence or worsening of this symptom... - Hyperhidrosis due to deep brain stimulation in a patient with essential tremor. Case reportAlan Diamond
Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
J Neurosurg 107:1036-8. 2007..Although a rare complication, hypothalamic dysfunction may occur as a stimulation-related side effect of Vim-DBS... 
Relationship between various clinical outcome assessments in patients with blepharospasmJoseph Jankovic
Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
Mov Disord 24:407-13. 2009..Both, JRS and BSDI, can be used to reliably assess blepharospasm in treatment trials...- Metoclopramide, an increasingly recognized cause of tardive dyskinesiaChristopher Kenney
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Houston, TX 77030, USA
J Clin Pharmacol 48:379-84. 2008 - Tourette's syndromeChristopher Kenney
Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
Am Fam Physician 77:651-8. 2008..Appropriate diagnosis and treatment can substantially improve quality of life and psychosocial functioning in affected children... - Bilateral pedunculopontine nuclei strokes presenting as freezing of gaitSheng Han Kuo
Department of Neurology, Parkinson s Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas 77030, USA
Mov Disord 23:616-9. 2008..We report a patient with bilateral PPN infarcts whose dominant clinical feature was freezing of gait, thus providing evidence that PPN is involved in human locomotion and that damage to the PPN may lead to abnormal gait... - Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trialJoseph M Ferrara
Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, Texas 77030, USA
J Neurol Sci 285:195-7. 2009..Adverse events were similar in frequency to previously published studies of PGB, the most common being drowsiness and dizziness... - Effect of vagal nerve stimulation in a case of Tourette's syndrome and complex partial epilepsyAlan Diamond
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
Mov Disord 21:1273-5. 2006..If verified by controlled clinical trials, this observation may provide insights into the pathophysiology of tics and may lead to a novel therapy for patients with severe TS... 
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseasesJing Zhang
Department of Pathology, University of Washington School of Medicine, Seattle, WA 98104, USA
Am J Clin Pathol 129:526-9. 2008..This first large-scale validation of a proteomic-discovered MAP suggests a panel of 8 CSF proteins that are highly effective at identifying PD and moderately effective at identifying AD...- Role of deep brain stimulation targeted to the pedunculopontine nucleus in Parkinson's diseaseChristopher Kenney
Expert Rev Neurother 7:585-9. 2007